1. Home
  2. Global Directory
  3. Brenda L. Danek

Brenda L. Danek

Associate
Chicago
  • 330 North Wabash Avenue, Suite 2800
  • Chicago, IL 60611
  • USA
Profile Experience

Brenda Danek, PhD is an associate in the Chicago office of Latham & Watkins and a member of the firm's Intellectual Property Litigation Practice.

Dr. Danek’s practice focuses primarily on patent litigation, with particular focus on antibody, biotechnology, and Hatch-Waxman litigation. She has extensive experience in litigating patent matters before both district court and inter partes review proceedings before the US Patent and Trademark Office. She has counseled clients in devising strategies for parallel proceedings before the district court and Patent Office. She has significant trial experience, including in managing fact and expert discovery, deposing and cross examining key expert witnesses, and arguing before both the district court and Patent Office. She has successfully represented clients in in the following technologies:

  • Pharmaceuticals
  • Biotechnology
  • Antibodies
  • Medical devices

Dr. Danek has also provided counseling on intellectual property licensing and antitrust issues.

Dr. Danek is also involved in pro bono matters, working with the National Immigrant Justice Center and Heartland Alliance to represent individuals seeking asylum.

Dr. Danek’s representative experience includes:

  • Astellas Institute for Regenerative Medicine et al. v. ImStem Biotech., Inc. (D. Mass.) – represents AIRM in a dispute concerning correcting inventorship and conversion of confidential materials related to production of human embryonic stem cells.
  • Pharmacyclics LLC v. Acerta Pharma B.V. (D. Del.) – represents Pharmacyclics in patent infringement cases related to Bruton’s tyrosine kinase inhibitors for the treatment of lymphoma.
  • MorphoSys AG v. Janssen Biotech Inc. and Genmab A/S (D. Del.) – represented Janssen and Genmab defending against an assertion of patent infringement for their breakthrough multiple myeloma antibody therapy, Darzalex.
  • Novartis AG v. Par Pham. Inc. (D. Del.) – represented Par Pharmaceuticals in multiple proceedings to challenge numerous patents covering Novarits’s Afinitor and Zortress products, including devising strategies for multiple proceedings before the Patent Office. The matter resulted in a favorable settlement after a favorable trial opinion and favorable Patent Office rulings.
  • Indivior Inc. v. Par Pharm. Inc. (D. Del.) – represented Par Pharmaceuticals in multiple proceedings related to challenging numerous patents covering Indivior’s Suboxone sublingual film formulation, including devising strategy for parallel proceedings to challenge patents in the Patent Office. The matter resulted in a favorable settlement after a favorable trial opinion and favorable Patent Office rulings.
  • Mallinckrodt Hosp. Prods. Inc. v. Praxair Inc. (D. Del.) – represented Mallinckrodt in defending against a challenge to ten patents covering its successful INOmax drug product and DSIR medical device, including defending multiple proceedings before the Patent Office.
  • Counseled a biotechnology company in a confidential dispute related to licensing rights and technology ownership for patents licensed from a university.

Qualifications and Education

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.